FDA Inspection 1197624 — Central Florida Eye Associates
The FDA completed an inspection of Central Florida Eye Associates on Feb 9, 2023 in Lakeland, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 9, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lakeland, FL (United States)
Additional Details
Clinical BA/BE